CAC 40
8 033,22 -58,64 (-0,72 %) Euro Stoxx 50
4 958,23 -31,65 (-0,63 %) Dow Jones
38 460,92 -42,77 (-0,11 %) EUR/USD
1,0730 +0,0029 (+0,27 %) Gold future
2 338,60 +0,20 (+0,01 %) Bitcoin EUR
59 187,25 -2 749,34 (-4,44 %)
Exact Sciences Corporation (EXAS)
Avant Bourse :
Exact Sciences Corporation
5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 6 500
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Kevin T. Conroy | Chairman of The Board & CEO | 1,54M | 26,75M | 1966 |
| Mr. Jeffrey T. Elliott CFA | EVP & CFO | 518,13k | S.O. | 1978 |
| Ms. Sarah Condella | Executive Vice President of Human Resources | 742,76k | S.O. | 1981 |
| Mr. Everett V. Cunningham | Chief Commercial Officer | 1,34M | S.O. | 1966 |
| Dr. Jorge A. Garces Ph.D. | Chief Science Officer | S.O. | S.O. | 1972 |
| Mr. Nassar Nizami | Chief Information Officer | S.O. | S.O. | S.O. |
| Ms. Megan Jones | Associate Manager of Investor Relations | S.O. | S.O. | S.O. |
| Mr. Tim Caprez | Chief Compliance Counsel & VP | S.O. | S.O. | S.O. |
| Mr. James Herriott | Senior VP, General Counsel & Secretary | S.O. | S.O. | 1980 |
| Mr. Vic Parker | Head of Sales | S.O. | S.O. | S.O. |
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Exact Sciences Corporation en date du 1 avril 2024 est 3. Les scores principaux sont Audit : 1; Société : 5; Droits des actionnaires : 3; Compensation : 7.
